Records containing: Neoplasms
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2012-03-27A Phase 1 Dose-Finding Study Of The Anti-Angiogenesis Agent, AG-013736, In Combinations Of Paclitaxel/Carboplatin, Weekly Paclitaxel, Docetaxel, Capecitabine, Gemcitabine/Cisplatin and Pemetrexed/Cisplatin In Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2012-03-26A Phase 1 Pharmacokinetic And Pharmacodynamic Study Of PF-03732010 In Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2012-03-26A Phase 1 Study In Patients With Advanced Solid Tumor To Evaluate The Pharmacokinetics And Safety Of AG-013736 At Single Doses Of 5 mg, 7 mg And 10 mg, And At Multiple Doses
-
CLINICAL_TRIALS study record update · 2012-02-24Hospital-based Home Care for Children With Cancer
-
CLINICAL_TRIALS study record update · 2012-02-07A Phase I Multiple Ascending Dose Study of BMS-844203 (CT-322) Monotherapy in Japanese Patients With Solid Tumors
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2012-01-23A Comparison of Different Scalp Cooling Systems for the Prevention of Chemotherapy Induced Alopecia
-
CLINICAL_TRIALS study record update · 2012-01-19A Randomized Double-blind, Parallel Group Study Comparing Olanzapine (Zyprexa) With Haloperidol (Novo-peridol) for the Relief of Nausea and Vomiting in Patients With Advanced Cancer
-
CLINICAL_TRIALS study record update · 2011-11-30Phase 1 Multiple Ascending Dose Study of BMS-754807 in Patients With Solid Tumors in Japan
-
CLINICAL_TRIALS study record update · 2011-08-08A Phase I Dose Escalating Study Of SU014813 In Patients With Solid Tumors Not Amenable To Conventional Therapy
-
CLINICAL_TRIALS study record update · 2011-07-15A Randomized, Open-Label, Multicenter Study Evaluating Thrombovascular Events in Subjects With Cancer Receiving Chemotherapy and Administered Epoetin Alfa Once or Three Times a Week for the Treatment of Anemia
-
CLINICAL_TRIALS study record update · 2011-07-07Anti-Angiogenic Chemotherapy: A Phase II Trial of Thalidomide, Celecoxib, Etoposide and Cyclophosphamide in Patients With Relapsed or Progressive Cancer
-
CLINICAL_TRIALS study record update · 2011-07-04ClinicalTrials.gov study NCT00046540
-
CLINICAL_TRIALS study record update · 2011-07-04Phase I Study of an Easy-to-Use Intravenous Formulation of Liposome Entrapped C-raf Antisense Oligonucleotide (LErafAON-ETU) Administered on a Weekly Schedule in Patients With Advanced Cancer
-
CLINICAL_TRIALS study record update · 2011-06-27A Clinical Phase 1 Safety And Pharmacokinetic/Pharmacodynamic Study Of PF-00299804 In Patients In Japan With Advanced Malignant Solid Tumors
-
CLINICAL_TRIALS study record update · 2011-06-15Randomized Controlled Trial Comparing Efficacy of Sorafenib Versus Sorafenib In Combination With Low Dose Cisplatin /Fluorouracil Hepatic Arterial InfUSion Chemotherapy in Patients With Advanced Hepatocellular Carcinoma
-
CLINICAL_TRIALS study record update · 2011-06-10A Pilot Study to Evaluate the Response Rate of Epoetin Alfa (PROCRIT) at 80,000 Units Every Three Weeks in Anemic Patients With Cancer Not Receiving Chemotherapy or Radiation Therapy
-
CLINICAL_TRIALS study record update · 2011-06-08A Multicenter Clinical Evaluation of the Safety Follow-up of Becaplermin or Placebo Gel Following Treatment of Chronic, Full Thickness Diabetic Ulcers
-
CLINICAL_TRIALS study record update · 2011-06-08A Phase I Dose Escalation Study on the Tolerability and Activity of TriN 2755 in Patients With Advanced Solid Tumors and Sarcomas Using Two Different Dosage Regimens
-
CLINICAL_TRIALS study record update · 2011-05-19A Pilot Study to Evaluate the Response Rate of PROCRIT (Epoetin Alfa) at 40,000 Units Once Weekly in Anemic Cancer Patients Not Receiving Chemotherapy
-
CLINICAL_TRIALS study record update · 2011-05-19Randomised Study to Evaluate the Effect of Early Intervention to Treat Anemia With Epoetin Alfa Versus Standard Use on Hemoglobin Levels and the Incidence of Blood Transfusions in Cancer Patients Receiving Chemotherapy
-
CLINICAL_TRIALS study record update · 2011-05-18The Effect of Subcutaneous r-HuEPO in Patients With Chronic Anemia Secondary to Chemotherapy
-
CLINICAL_TRIALS study record update · 2011-05-18A Pilot Study to Evaluate the Response Rate of PROCRIT� (Epoetin Alfa) at 60,000 Units Every Two Weeks in Anemic Cancer Patients Not Receiving Chemotherapy Or Radiation Therapy
-
CLINICAL_TRIALS study record update · 2011-05-18The Effect of Subcutaneous r-HuEPO in Patients With Chronic Anemia Secondary to Cisplatin Chemotherapy
-
CLINICAL_TRIALS study record update · 2011-05-18The Effect of Subcutaneous r-HuEPO in Patients With Chronic Lymphocytic Leukemia
-
CLINICAL_TRIALS study record update · 2011-04-28A Phase 2 Study of ET-743 in Subjects With Advanced Breast Cancer